EricIFelnerMD

Professor of Pediatrics, Division of Pediatric Endocrinology, Emory University School of Medicine AND Adjunct Professor of Chemical & Biomolecular Engineering, School of Chemical & Biomolecular Engineering, Georgia Institute of Technology

Join to view full profile

Dr. Felner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Felner's full profile

Already have an account?

Office
2015 Uppergate Dr
Atlanta, GA 30322
Phone+1 404-785-0935

Fax+1 404-785-9200

Education & Training

University of Texas Southwestern Medical CenterFellowship, Pediatric Endocrinology, 1997 - 2000
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1994 - 1997
Emory University School of MedicineClass of 1994

Certifications & Licensure

GA State Medical License 2003 - 2025
LA State Medical License 2000 - 2003
TX State Medical License 1996 - 2003
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab Start of enrollment: 2008 Oct 01
Withdrawn
Phase 2
Insulin Delivery Using Microneedles in Type 1 Diabetes Start of enrollment: 2008 Sep 01
Completed
Phase 2, Phase 3
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Jan 01
Completed
Phase 2
Glucose Measurement Using Microneedle Patches Start of enrollment: 2017 Dec 21
Completed
Not Applicable
Type 1 Diabetes Extension Study Start of enrollment: 2016 Aug 18
Recruiting
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus Start of enrollment: 2019 Nov 27
Completed
Phase 4
Siplizumab in T1DM Start of enrollment: 2023 Apr 26
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Aldena STAR Particles Start of enrollment: 2024 Feb 07
Recruiting
Not Applicable
Roles: Principal Investigator
Lidocaine Administration Using STAR Particles Start of enrollment: 2023 Mar 19
Completed
Not Applicable
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
Kyriakie Sarafoglou, Mimi S Kim, Maya Lodish, Eric I Felner, Laetitia Martinerie
The New England Journal of Medicine. 2024-08-08
1 citations
Tolerability of a piezoelectric microneedle electroporator in human subjects.
Chao-Yi Lu, Pankaj Rohilla, Eric I Felner, Gaurav Byagathvalli, Erkan Azizoglu
Bioengineering & Translational Medicine. 2024-07-01
1 citations
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.
Jennifer L Miller, Evelien Gevers, Nicola Bridges, Jack A Yanovski, Parisa Salehi
Obesity. 2024-02-01

Journal Articles

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Teresa Quattrin, Michael J Haller, Andrea K Steck, Eric I Felner, The New England Journal of Medicine